This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 378Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2227 | DCP, (cut-off value of 86 mAU/mL) | Protein | Human | DCP upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.001 | Serum | 25382443 |
2228 | AFP | Protein | Human | AFP upregulated in HCC | Diagnostic | HCC v/s Non-HCC | p < 0.001 | Serum | 29163838 |
2229 | DCP | Protein | Human | DCP upregulated in HCC | Diagnostic | HCC v/s Non-HCC | p < 0.001 | Serum | 29163838 |
2230 | AFP, DCP, (DCP >40 mAU/mL, AFP >20 ng/mL) | Protein | Human | AFP and DCP upregulated in HCC | Diagnostic | HCC v/s Non-HCC | p < 0.001 | Serum | 29163838 |
2231 | TP73-AS1 | LncRNA | Human | Upregulated in HCC (with more than 2 fold change) | Diagnostic and Prognostic | HCC v/s Normal; associated with worse clinicopathological features, poorer prognosis and shorter survival | p < 0.001 | Tissue | 28403886 |
2232 | CCAT2 | LncRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.05 | Tissue | 27347113 |
2233 | UCA1 | LncRNA | Human | Upregulated in HCC | Diagnostic | HCC v/s Normal | p < 0.05 | Tissue | 28271214 |
2236 | MALAT1 | LncRNA | Human, Mice and cell lines | Upregulated in HCC with Fold change=3.233 | Diagnostic | HCC v/s Normal | p < 0.05 | Tissue | 27993818 |
2237 | ANRIL | LncRNA | Human | Upregulated in HCC with Fold change >1.0 | Diagnostic | HCC v/s Normal | p < 0.01 | Tissue | 25966845 |
2240 | lncRNA-hPVT1 | LncRNA | Human | Upregulated in HCC and higher hPVT1 expression levels in HCC tissues significantly correlated with markedly reduced recurrence-free survival | Diagnostic and Prognostic | HCC v/s Normal; associated with recurrence and survival in patients | p < 0.001 | Tissue | 25043274 |
2241 | DANCR | LncRNA | Human | Upregulated in HCC | Diagnostic and Prognostic | HCC v/s Normal/Cirrhosis/CHB;associated with metastasis of patients | p < 0.001 | Plasma | 27919960 |
2242 | RP11-160H22.5 | LncRNA | Human | Upregulated in HCC with Fold change >2.0 | Diagnostic | HCC v/s Normal | p < 0.01 | Plasma | 25714016 |
2243 | XLOC_014172 | LncRNA | Human | Upregulated in HCC with Fold change >2.1 | Diagnostic and Prognostic | HCC v/s Normal; associated with metastatsis of patients | p < 0.01 | Plasma | 25714016 |
2244 | LOC149086 | LncRNA | Human | Upregulated in HCC with Fold change >2.0 | Diagnostic and Prognostic | HCC v/s Normal; associated with metastatsis of patients | p < 0.01 | Plasma | 25714016 |
2245 | RP11-160H22.5, XLOC_014172, LOC149086 | LncRNA | Human | Upregulated in HCC with Fold change >2.0 | Diagnostic and Prognostic | HCC v/s Normal; associated with metastatsis of patients | p < 0.01 | Plasma | 25714016 |
2246 | HLA-C | RNAs | Human | Upregulated in HCC and CHC v/s normal (with 67 fold change) | Diagnostic | HCC and CHC v/s normal | p < 0.01 | Tissue | 11401510 |
2247 | B2M | RNAs | Human | Upregulated in HCC and CHC v/s normal (with 67 fold change) | Diagnostic | HCC and CHC v/s normal | p < 0.01 | Tissue | 11401510 |
2248 | BR1 | RNAs | Human | Upregulated in HCC and CHC v/s normal (with 19 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2249 | GPC3 | RNAs | Human | Upregulated in HCC than CHC and normal (with nearly 15 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2250 | UBD | RNAs | Human | Upregulated in HCC than CHC and normal (with nearly 12 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2251 | CXCL10 | RNAs | Human | Upregulated in HCC than CHC and normal (with nearly 13 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2252 | CYP3A4 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 42 and 50 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2253 | CYP4A11 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 17 and 30 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2254 | SLC22A1 | RNAs | Human | Downregulated in HCC than CHC and normal (with nearly 8 and 17 fold change) | Diagnostic | HCC v/s CHC and normal | p < 0.01 | Tissue | 11401510 |
2255 | Enoyl-CoA hydratase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15221772 |
2256 | Tropomyosin-beta-chain | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
2257 | Ketohexokinase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
2258 | Liver type aldolase | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 15221772 |
2259 | Arginase 1 | Protein | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.01 | Tissue | 15221772 |
2260 | CDK4 | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2261 | Bax | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2262 | NOTCH4 | RNAs | Human | Upregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2263 | ISGF3G | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2264 | TNF | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2265 | VISA | RNAs | Human | Downregulated | Diagnostic and prognostic | HCC with Cirrhosis v/s HCC without Cirrhosis | p < 0.05 | Tissue | 18959789 |
2267 | SPP1 | RNAs and Protein | Human | Upregulated in PT than PN (with 3 fold change) | Diagnostic | Metastatic HCC v/s Primary HCC | p < 0.01 | Tissue | 12640447 |
2268 | LIMK1, CENPE, FZD2, ENO2, ITGA9, COPA, KIAA0660, GTF2H1, VPS41, RGS20, MATK, STOML1, BASP1, EPB42, ALDH3B2, MEL, CAT56, RAB3A, PSCD3, PLD2, ADCYAP1R1, ALDH3B1, RHD, CSF3R, KIAA0063, KIAA0296, LRP6, ENO3, CTRB1, YES1, IncytePD:1404153, GYS1, MDFI, GABRE, IncytePD:2685601, CD3Z, DTYMK, SPTBN2, IncyteP | RNAs | Human | Upregulated in PT than PN (with 3 fold change) | Diagnostic | Metastatic HCC v/s Primary HCC | p < 0.01 | Tissue | 12640447 |
2292 | RPS5 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 6.35) and (v/s HCV associated HCC with ratio of 2.38) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2293 | KRT8 | RNAs | Human | Upregulated in HBV associated HCC ( v/s normal with fold change 5.68) and (v/s HCV associated HCC with ratio 3.19) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2294 | CFLAR | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 2.86) and (v/s HCV associated HCC with ratio of 2.09) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2295 | ATP5F1 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 4.19) and (v/s HCV associated HCC with ratio of 3.52) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2296 | IGFBP2 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 3.37) and (v/s HCV associated HCC with ratio of 2.49) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2297 | MAP3K5 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 3.76) and (v/s HCV associated HCC with ratio of 2.33) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2298 | MMP9 | RNAs | Human | Upregulated in HBV associated HCC (v/s normal samples with fold change 7.43) and (v/s HCV associated HCC with ratio of 3.74) | Diagnostic | HBV associated HCC v/s normal and HCV associated HCC | p < 0.05 | Tissue | 18932288 |
2299 | VIM | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 8.61) and (ratio of HBV-HCC v/s HCV-HCC 0.28) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |
2300 | ACTB | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 4.13) and (ratio of HBV-HCC v/s HCV-HCC 0.37) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |
2301 | GAPD | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 5.27) and (ratio of HBV-HCC v/s HCV-HCC 0.29) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |
2302 | CD58 | RNAs | Human | Upregulated in HCV associated HCC (v/s normal samples with fold change 4.68) and (ratio of HBV-HCC v/s HCV-HCC 0.31) | Diagnostic | HCV associated HCC v/s normal and HBV associated HCC | p < 0.05 | Tissue | 18932288 |
2304 | CLDN10 | RNAs | Human | Upregulated in Cirrhosis v/s control and early and advanced HCC | Diagnostic | Cirrhosis v/s Low/High grade dysplastic nodules, normal and early/Late HCC | p < 0.05 | Tissue | 17393520 |
2305 | GREM2 | RNAs | Human | Upregulated in dysplasia v/s control and early/advanced HCC | Diagnostic | dysplasia v/s early/late HCC and normal | p < 0.05 | Tissue | 17393520 |